Five Connecticut biotech companies working on solutions to prevent, treat, manage, or test for COVID-19 infection recently participated in a virtual panel discussion organized by BioCT, an advocacy group for Connecticut’s bioscience cluster, and moderated by Mostafa Analoui from the University of Connecticut’s Office of the Vice President for Research and Technology Incubation Program (TIP).

Read the entire article by Christopher DeFrancesco ’95 (CLAS) posted on UConn Today April 21, 2020: The COVID-19 Arms Race

Photo: Anthony T. Vella, professor and Boehringer Ingelheim chair in immunology, left, speaks with President and CEO, Bijan Almassian at CaroGen Corp.’s technology incubation lab in Farmington on Dec. 12, 2016. (Peter Morenus/UConn Photo)